Format

Send to

Choose Destination
JAMA Intern Med. 2015 Oct;175(10):1725-6. doi: 10.1001/jamainternmed.2015.4003.

Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness-Reply.

Author information

1
Department of Medicine, University of Colorado School of Medicine, Aurora.
2
San Francisco Veterans Affairs Medical Center, Center for Research on Aging at the Jewish Home of San Francisco, San Francisco, California3Division of Geriatrics, Department of Medicine, University of California, San Francisco, San Francisco.
3
Center for Learning Health Care, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
PMID:
26436751
DOI:
10.1001/jamainternmed.2015.4003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center